PDE4B and chronic obstructive pulmonary disease: Based on the comprehensiveresearch presented in this study, itcan be concluded that monosubstituted cinnamic acid derivatives representa promising class of PDE4B inhibitors with significant therapeuticpotential for inflammatory diseases such as COPD.